Vivos Therapeutics

(NASDAQ) VVOS

Current Price$0.79

Market Cap$11.46M

Since IPO (2020)-100%

5 Year-100%

1 Year-70%

1 Month-28%

Vivos Therapeutics Financials at a Glance

Market Cap

$11.46M

Revenue (TTM)

$17.44M

Net Income (TTM)

$21.23M

EPS (TTM)

$-2.24

P/E Ratio

-0.38

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$0.79

Volume

236,908

Open

$0.86

Price

$0.79

Volume

236,908

Open

$0.86

Previous Close

$0.78

Daily Range

$0.76 - $0.86

52-Week Range

$0.76 - $7.95

Dividend

$0.00

Beta (Volatility)

0.91 (Low)

Price

$0.79

Volume

236,908

Open

$0.86

Previous Close

$0.78

Daily Range

$0.76 - $0.86

52-Week Range

$0.76 - $7.95

VVOS News

Vivos Reports 7% Sales Drop

Motley Fool Markets TeamAug 20, 2025

Vivos Therapeutics Unveils New Model

Motley Fool Markets TeamAug 19, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Vivos Therapeutics

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

268

CEO

R. Kirk Huntsman

Website

www.vivos.com

Headquarters

Highlands Ranch, CO 80129, US

VVOS Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-655%

Return on Capital

-3%

Return on Assets

-84%

Earnings Yield

-2.63%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$11.46M

Shares Outstanding

13.49M

Volume

236.91K

Avg. Volume

209.08K

Financials (TTM)

Gross Profit

$10.54M

Operating Income

$19.89M

EBITDA

$18.59M

Operating Cash Flow

$15.26M

Capital Expenditure

$2.34M

Free Cash Flow

$17.60M

Cash & ST Invst.

$2.03M

Total Debt

$13.50M

Vivos Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$3.82M

+3.4%

Gross Profit

$2.99M

+42.5%

Gross Margin

78.14%

N/A

Market Cap

$11.46M

N/A

Market Cap/Employee

$105.09K

N/A

Employees

109

N/A

Net Income

$6.95M

-146.0%

EBITDA

$5.94M

-123.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$11.47M

-341.6%

Accounts Receivable

$1.58M

+267.7%

Inventory

$0.00

N/A

Long Term Debt

$4.42M

+327.2%

Short Term Debt

$9.08M

+1803.6%

Return on Assets

-84.41%

N/A

Return on Invested Capital

-2.81%

N/A

Free Cash Flow

$4.71M

-51.5%

Operating Cash Flow

$3.81M

-29.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OSRHOSR Holdings, Inc.

OSRHOSR Holdings, Inc.$0.46-38.19%

LPCNLipocine Inc.

LPCNLipocine Inc.$2.29-0.87%

AMSAmerican Shared Hospital Services

AMSAmerican Shared Hospital Services$1.34+0.75%

COCHEnvoy Medical, Inc.

COCHEnvoy Medical, Inc.$0.68+6.72%

ADGMAdagio Medical Holdings, Inc.

ADGMAdagio Medical Holdings, Inc.$1.05-3.67%

ALURAllurion Technologies Inc.

ALURAllurion Technologies Inc.$0.74+8.82%

CODXCo-Diagnostics, Inc.

CODXCo-Diagnostics, Inc.$1.53-6.13%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$94.75+0.12%

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

NOKNokia

NOKNokia$12.46+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

HOODRobinhood Markets

HOODRobinhood Markets$71.20-0.13%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.67+0.39%

Questions About VVOS

What is the current price of Vivos Therapeutics?

Vivos Therapeutics is trading at $0.78 per share.

What is the 52-week range for Vivos Therapeutics?

Over the past 52 weeks, Vivos Therapeutics has traded between $0.76 and $7.95.

How much debt does Vivos Therapeutics have?

As of the most recent reporting period, Vivos Therapeutics reported total debt of $13.50M.

How much cash does Vivos Therapeutics have on hand?

Vivos Therapeutics reported $2.03M in cash and cash equivalents in its most recent financial results.

What is Vivos Therapeutics’s dividend yield?

Vivos Therapeutics does not currently have a dividend yield.

Vivos Therapeutics

Vivos Therapeutics Financials at a Glance

VVOS News

Vivos Reports 7% Sales Drop

Vivos Therapeutics Unveils New Model

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Vivos Therapeutics

VVOS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Vivos Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About VVOS

What is the current price of Vivos Therapeutics?

What is the 52-week range for Vivos Therapeutics?

How much debt does Vivos Therapeutics have?

How much cash does Vivos Therapeutics have on hand?

What is Vivos Therapeutics’s dividend yield?

Premium Investing Services